Cancer-associated fibroblasts and metabolic reprogramming predict pathologic response to neoadjuvant PD-1 blockade in resected non-small cell lung cancer.

Cell Oncol (Dordr) · 2025 · PMC12238122 · PMID 40358847

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

Our analysis revealed a consistent trend of elevated myCAF, iCAF, and apCAF abundance in non-MPR patients compared to MPR patients, although these differences did not reach statistical significance ( p > 0.05) (Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.